GW677954
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GW677954, covering 2012-06-04 to 2012-06-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus [Phase 2]